CClinicalTrials.gg
CompletedNCT00885716Updated Jan 9, 2025

A Shared Decision Making Training for Inpatients With Schizophrenia

An interventional study of patient training in shared decision making and cognitive training in Schizophrenia and Schizoaffective Disorder, sponsored by Technical University of Munich. Completed at 1 site in Germany. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-01-09.

Sponsored by Technical University of Munich · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Patients suffering from schizophrenia who attend the communication skills program engage more deeply in therapeutic reasoning and treatment decisions. This results in stronger preferences to participate, greater perceived involvement and better long term adherence compared to patients who do not attend the training.

02

Conditions studied

  • Schizophrenia
  • Schizoaffective Disorder
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 61 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Technical University of Munich is the lead sponsor of 315 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male and female inpatients with a diagnosis of schizophrenia/schizoaffective disorder according to ICD 10
  • between 18 and 60 years of age are eligible for the study
  • informed consent
  • inpatients

Exclusion criteria

Exclusion Criteria:

  • poor German language skills
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    communication skills training

    group training in shared decision making.

    Behavioral: patient training in shared decision making

  • Active comparator
    cognitive training

    standard group training of cognitive skills (Konzentrationstraining)

    Behavioral: cognitive training

Interventions

  • Behavioralpatient training in shared decision making
  • Behavioralcognitive training
06

What researchers measure

Primary outcomes

  1. Decision Self Efficacy

    Time frame: post intervention

Secondary outcomes

  1. Adherence to medication

    Time frame: 6 months post intervention

  2. Participation preferences

    Time frame: post intervention

  3. Treatment satisfaction

    Time frame: post intervention

07

Study locations

1 site
  • Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München
    München, Germany
08

References and documents

Publications

  • Hamann J, Mendel R, Meier A, Asani F, Pausch E, Leucht S, Kissling W. "How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia. Psychiatr Serv. 2011 Oct;62(10):1218-21. doi: 10.1176/ps.62.10.pss6210_1218. PubMed 21969650 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00885716
Lead sponsor
Technical University of Munich
Collaborators
The German-Israeli Foundation for Scientific Research and Development
First posted
Apr 22, 2009
Start date
May 2009
Primary completion
Jun 2010
Completion
Jun 2010
Last update
Jan 9, 2025

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion